Sign In
Buy VERV
$11.13
+0 (+0%)
At Close: Oct 24, 2025
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Verve Therapeutics, Inc. - VERV
12:00pm, Tuesday, 15'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Verve Therapeutics, Inc. ("Verve" or the "Company") (NASDAQ:VERV). Such invest
Lost Money on Verve Therapeutics, Inc.(VERV)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
11:25am, Tuesday, 15'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securitie
Verve Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Stockholders Are Urged To Help The Schall Law Firm
11:00am, Tuesday, 15'th Oct 2024
LOS ANGELES, CA / ACCESSWIRE / October 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Verve Therapeutics, Inc. ("Ver
Lost Money on Verve Therapeutics, Inc.(VERV)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
07:15am, Tuesday, 15'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securitie
NEW YORK CITY, NY / ACCESSWIRE / October 15, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Verve Th
Shareholders that lost money on Verve Therapeutics, Inc.(VERV) should contact Levi & Korsinsky about pending Class Action - VERV
05:45am, Tuesday, 15'th Oct 2024
NEW YORK , Oct. 15, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Verve Therapeutics, Inc. ("Verve Therapeutics" or the "Company") (NASDAQ: VERV) of a class action securities lawsu
Class Action Filed Against Verve Therapeutics, Inc. (VERV) - October 28, 2024 Deadline to Join – Contact Levi & Korsinsky
04:30pm, Monday, 14'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securitie
NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
Class Action Filed Against Verve Therapeutics, Inc. (VERV) Seeking Recovery for Investors – Contact Levi & Korsinsky
01:24pm, Monday, 14'th Oct 2024
NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Verve Therapeutics, Inc. ("Verve Therapeutics" or the "Company") (NASDAQ: VERV) of a class action securities law
VERV LAWSUIT ALERT: Levi & Korsinsky Notifies Verve Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
11:15am, Monday, 14'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securitie
The Schall Law Firm Encourages Investor Participation In A Securities Fraud Case Against Verve Therapeutics, Inc.
11:00am, Monday, 14'th Oct 2024
LOS ANGELES, CA / ACCESSWIRE / October 14, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Verve Therapeutics, Inc. ("Ver
Class Action Filed Against Verve Therapeutics, Inc. (VERV) - October 28, 2024 Deadline to Join - Contact Levi & Korsinsky
10:45am, Monday, 14'th Oct 2024
NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securitie
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics
10:25am, Monday, 14'th Oct 2024
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Verve To Contact Him Directly To Discuss Their Options If you suffe
NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securitie
NEW YORK, NY / ACCESSWIRE / October 14, 2024 / If you suffered a loss on your Verve Therapeutics, Inc. (NASDAQ:VERV) investment and want to learn about a potential recovery under the federal securitie
